Congratulations to the Regenerative Engineering and Translational Medicine team on receiving a 4.5 CiteScore for the year 2022, and a 2.6 as their preliminary Impact Factor!
Huge congratulations to Regenerative Engineering and Translational Medicine’s Editor-in-Chief, Dr. Cato Laurencin, on earning the 2023 Priestley Medal, the highest honor of the American Chemical Society, for his work on polymeric materials and composites for biological use and his tireless leadership efforts in supporting inclusion, diversity, equity, and anti-racism. He is also the recipient of the 2023 Diversity, Equity, & Inclusion (DEI) Award of the Society of Biomaterials!
Regenerative Engineering and Translational Medicine is the leading journal in the field covering convergence research in regeneration.
Take a look at the journal's most highly cited articles published in 2022 and 2023!
Take a look at the journal's most highly downloaded articles in the year 2023!
Take a look at the journal's most highly cited articles published in 2021 and 2022.
Take a look at the journal's most highly downloaded articles in the year 2022.